Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02539927 · ClinicalTrials.gov registry record
Validation Study of the SAGIT® Instrument in Acromegaly
A clinical trial, sponsored by Ipsen.
- Completed
- Registry status
- 227
- Enrollment target
NCT02539927 is a clinical trial that has completed, run by Ipsen. The registered enrollment target is 227 participants.
The verdict
NCT02539927 has completed, sponsored by Ipsen.
- COMPLETED
- Registry status
- 227 participants
- Enrollment target
Study Summary
Patients will be treated in accordance with the standard medical practice of the hospital where they have been recruited during their participation in this study. No additional assessments or tests will be required. SAGIT® is a new instrument developed by a group of acromegaly experts to help practicing endocrinologists to manage acromegalic patients and disease activity in their clinical practice and define acromegaly staging. It reports 5 elements: Signs and symptoms - S; Associated comorbidities - A; Growth hormone (GH) concentration - G; Insulin-like growth factor 1(IGF-1) concentration -I; Tumour size- T. The instrument has been pre evaluated during a qualitative pilot study. The purpose of the validation study is to define and validate the scoring of the SAGIT® instrument.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 227 participants |
| Start Date | 2015-07 |
| Est. Completion | 2018-09-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02539927
The ClinicalTrials.gov registry entry for NCT02539927 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 227 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ipsen, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02539927 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02539927 about?
NCT02539927 is a clinical study titled "Validation Study of the SAGIT® Instrument in Acromegaly". Patients will be treated in accordance with the standard medical practice of the hospital where they have been recruited during their participation in this study. No additional assessments or tests will be required. SAGIT® is a new instrument developed by a group of acromegaly experts to help pract...
What is the current status of trial NCT02539927?
This trial is currently completed. The enrollment target is 227 participants. The study started on 2015-07. Estimated completion is 2018-09-03.
Who is sponsoring clinical trial NCT02539927?
This trial is sponsored by Ipsen, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.